Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-BCR Polyclonal Antibody

Catalog #:   PHC87501 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P11274
Overview

Catalog No.

PHC87501

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human BCR (Lys174-Asp331).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Renal carcinoma antigen NY-REN-26,BCR1,BCR,D22S11,Breakpoint cluster region protein

Purification

Purified by antigen affinity column.

Accession

P11274

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • WESTERN BLOT
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with BCR antibody (PHC87501) at 1 μg/ml.

    Lane 1: Recombinant protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 20 kDa
    Observed MW: 20 kDa
References

Patterns of adjuvant bone modifying agent use in patients with early-stage breast cancer in the United States., PMID:40500761

Imprints of somatic hypermutation on B-cell receptor immunoglobulins post-infection versus post-vaccination against SARS-CoV-2., PMID:40489958

Synergy and antagonism in the integration of BCR and CD40 signals that control B-cell population expansion., PMID:40473841

MBD2 promotes B cell differentiation and BCR signaling in systemic lupus erythematosus by regulating the LEF-1-PTEN-PI3K axis., PMID:40467564

Microfluidics combined with electron microscopy for rapid and high-throughput mapping of antibody-viral glycoprotein complexes., PMID:40461656

Sialylated IgG expressed in triple-negative breast cancer cells promotes cancer progression by promoting glycolysis., PMID:40457370

CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma., PMID:40436855

B-cell lymphoma: Advances in pathogenesis, diagnosis, and targeted therapies., PMID:40435909

Differentiation-dependent EBF1 Activity Determines CD22 Transcription and Leukemia Sensitivity to Inotuzumab Ozogamicin., PMID:40435412

Dual generation of stereo- and linear-specific monoclonal antibodies through B-cell receptors by DNA and cell immunization for therapeutic applications., PMID:40412732

Extracellular Inosine Induces Anergy in B Cells to Alleviate Autoimmune Hepatitis., PMID:40409684

B cell receptor silencing reveals origin and dependencies of high-grade B cell lymphomas with MYC and BCL2 rearrangements., PMID:40402557

Intra-tumoral spatial heterogeneity in breast cancer quantified using high-dimensional protein multiplexing and single cell phenotyping., PMID:40399910

B-cell immune repertoire sequencing in tobacco cigarette smoking, vaping, and chronic obstructive pulmonary disease in the COPDGene cohort., PMID:40386772

Single cell transcriptomics correlate avian coronavirus prime vaccination efficacy with antigen-presenting cell preference., PMID:40382358

Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring., PMID:40377367

Molecular characterization and predictors of relapse in patients with Ph + ALL after frontline ponatinib and blinatumomab., PMID:40369607

Dasatinib Pharmacokinetics and Advanced Nanocarrier Strategies: from Systemic Limitations to Targeted Success., PMID:40360939

Insertional diversification of the immunoglobulin heavy chain in chronic lymphoproliferative disorders., PMID:40356055

[Application of next-generation sequencing technology for the investigation of immunoglobulin variable region characteristics and their prognostic significance in patients with chronic lymphocytic leukemia]., PMID:40355356

Antigen mobility regulates the dynamics and precision of antigen capture in the B cell immune synapse., PMID:40354540

Denosumab as an immune modulator in HER2-negative early breast cancer: results of the window-of-opportunity D-BIOMARK clinical trial., PMID:40350430

Chimeric autoantibody receptor T cells clonally eliminate B cells producing autoantibodies against IFN-γ., PMID:40344086

The Quest for Antibodies and Other Acquired Immune Receptors: A Historical Perspective., PMID:40341816

Somatic hypermutation generates antibody specificities beyond the primary repertoire., PMID:40339575

Naive and Memory B Cell BCR Repertoires in Individuals Immunized with an Inactivated SARS-CoV-2 Vaccine., PMID:40333337

The evolving therapeutic revolution in adult acute lymphoblastic leukemia., PMID:40323723

Induced B cell receptor diversity predicts PD-1 blockade immunotherapy response., PMID:40314973

Regulatory T cell epitope content in human antibodies decreases during maturation., PMID:40313951

Management of Adult Acute Lymphoblastic Leukemia: A Review., PMID:40310617

Impact of memory T cells on SARS-CoV-2 vaccine response in hematopoietic stem cell transplant., PMID:40294012

Monoclonal antibodies derived from B cells in subjects with cystic fibrosis reduce Pseudomonas aeruginosa burden in mice., PMID:40272253

Efficient boosting of Omicron-reactive memory B cells after breakthrough infection protects from repeated exposure., PMID:40264792

Critical roles of chronic BCR signaling in the differentiation of anergic B cells into age-associated B cells in aging and autoimmunity., PMID:40249819

Disease-specific B cell clones are shared between patients with Crohn's disease., PMID:40246842

Reading of human acute immune dynamics in omicron SARS-CoV-2 breakthrough infection., PMID:40231451

Decoding B Cells in Autoimmune Diseases Through ScRNA + BCR-Seq: Current Knowledge and Future Directions., PMID:40214492

Pharmacovigilance study of adverse reactions of anti-HER-2 drugs for the treatment of HER-2-positive breast cancer based on the FAERS database., PMID:40205546

Blinatumomab in combination with olverembatinib and concurrent intrathecal chemotherapy successfully treated a chronic myeloid leukemia relapse with central nervous system blast crisis: case report and literature review., PMID:40202540

Myeloid-Driven Immune Suppression Subverts Neutralizing Antibodies and T Cell Immunity in Severe COVID-19., PMID:40183283

Glofitamab in refractory or relapsed diffuse large B cell lymphoma after failing CAR-T cell therapy: a phase 2 LYSA study., PMID:40181090

A ROR1 targeted bispecific T cell engager shows high potency in the pre-clinical model of triple negative breast cancer., PMID:40165319

CRISPR screens with trastuzumab emtansine in HER2-positive breast cancer cell lines reveal new insights into drug resistance., PMID:40165206

Supervised fine-tuning of pre-trained antibody language models improves antigen specificity prediction., PMID:40163503

Immunotherapy followed by cetuximab in locally advanced/metastatic cutaneous squamous cell carcinomas: the I-TACKLE trial., PMID:40154210

Impact of Protein Kinase C Activation and Monoclonal Antibodies on Immune Checkpoint Regulation and B Cell Function in Patients with Chronic Lymphocytic Leukemia., PMID:40149717

CHIKV mRNA vaccines encoding conserved structural/envelope proteins confer broad cross-lineage protection against infection., PMID:40148284

Lung-resident memory B cells maintain allergic IgE responses in the respiratory tract., PMID:40139187

B-cell depletion therapy reduces retinal inflammation in experimental autoimmune uveoretinitis., PMID:40117810

Activated polyreactive B cells are clonally expanded in autoantibody positive and patients with recent-onset type 1 diabetes., PMID:40117290

Datasheet

Document Download

Anti-BCR Polyclonal Antibody.pdf

 

$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-BCR Polyclonal Antibody [PHC87501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only